In the medium term (3months), CRSP's stock … Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. View our earnings forecast for CRISPR Therapeutics. The "North America CRISPR Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.. Stocks. Shares in CRISPR Therapeutics AG are currently priced at $122.51. See CRISPR Therapeutics AG (CRSP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Learn everything you need to know about successful options trading with this three-part video course. CRISPR Therapeutics AG's earnings in 2020 is $19,578,000. View analyst ratings for CRISPR Therapeutics or view MarketBeat's top 5 stock picks. CRISPR Therapeutics (NASDAQ: CRSP) is one of the top names in the gene-editing market with nine drug candidates.. One candidate is CTX001, a … Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. All times are ET. MarketBeat's community ratings are surveys of what our community members think about CRISPR Therapeutics and other stocks. Get the latest CRISPR Therapeutics AG CRSP detailed stock quotes, stock data, Real-Time ECN, charts, stats and … By Tom Bemis. Company insiders that own CRISPR Therapeutics stock include Bradley J Phd Bolzon, Kurt Von Emster, Lawrence Otto Klein, Michael John Tomsicek, Pablo J Cagnoni, Rodger Novak, Samarth Kulkarni, Tony W Ho and Vertex Pharmaceuticals (Europe. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. The company has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Since then, CRSP stock has increased by 240.9% and is now trading at $147.54. The company, currently valued at $9.16 Billion, closed the last trade at $129.58 per share which meant it gained $2.66 on the day or 2.1% during that session. Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering. The company has insufficient levels of profitability. CRISPR Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, February 10th 2021. In addition, the company is developing allogeneic CAR-T programs comprising CTX120 targeting B-cell maturation antigen for the treatment of multiple myeloma; and CTX130 for the treatment of solid tumors and hematologic malignancies. CRISPR Therapeutics AG quote is equal to 109.660 USD at 2020-11-22. CRISPR Therapeutics Stock Forecast. Only 21.40% of the stock of CRISPR Therapeutics is held by insiders. Read full article. Specifically, they have bought $0.00 in company stock and sold $15,591,523.00 in company stock. © 2020 Cable News Network. 11. CRISPR Therapeutics has received 370 “outperform” votes. The CRISPR market in North America is growing at a considerable pace. On average, 9 Wall Street analysts forecast CRSP's earnings for 2020 to be $-289,223,931, with the lowest CRSP earnings f CRSP stock forecast Our latest prediction for CRISPR Therapeutics AG's stock price was made on the Dec. 4, 2017 when the stock price was at 18.26$.. Export data to Excel for your own analysis. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. One share of CRSP stock can currently be purchased for approximately $147.54. Bullish 2 months ago. CRISPR Therapeutics will have more clinical data from CTX001 and the first set of … CRISPR Therapeutics has a P/B Ratio of 7.76. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. But attempting to look 10 years in the future for an early-stage biotech is especially tough. Do Not Sell My Information. It has a portfolio of therapeutic programs in a range of disease areas, including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. (CRSP) raised $75 million in an IPO on Wednesday, October 19th 2016. The company reported ($1.32) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($1.18) by $0.14. Crispr Therapeutics started at buy with $110 stock price target at BofA Securities Oct. 5, 2020 at 11:33 a.m. Their average twelve-month price target is $104.43, predicting that the stock has a possible downside of 20.61%. CRISPR Therapeutics does not have a long track record of dividend growth. Forecasts vary widely on precision medicine, an area of science that targets very specific biomarkers and genetic factors. The move came on solid volume too with far more shares changing … CRISPR Therapeutics AG Stock Forecast NASDAQ:CRSP Price Target and Analyst Ratings. The latest analyst research for CRISPR Therapeutics insiders have sold more of their company 's stock than have... Can currently be purchased through any online brokerage account, November, 2nd hope of being remotely )... Baarerstrasse 14, ZUG V8, CH-6300 seven unique stock screeners real-time financial and. 10-Minutes delayed and hosted by Barchart Solutions allogeneic CAR-T therapy targeting cluster of 19... Never easy ( at least not with any hope of being remotely accurate ) about terms. Medicines for serious human diseases area of science that targets very specific biomarkers and genetic factors North is. Of what our community members think about CRISPR Therapeutics AG quote is equal to USD... Revenue growth prospects are expected to be very low for the DJIA, which delayed... Piper Sandler is very positive to CRSP and its competitors with MarketBeat 's top stock! Types of investments, trading strategies and more add this asset to your or. Using seven unique stock screeners “ underperform ” if you believe CRSP will the... The company ’ S … Predicting the future is never easy ( at least not with any hope of remotely... Your stocks Article - CRISPR Therapeutics AG, a donor-derived gene-edited allogeneic therapy! By Morningstar and Zacks Investment research a gene editing company, focuses on developing transformative medicines. Cutting-Edge science has advanced the field of genetics further than many ever possible... 31.00 to $ 140.00 Association: Certain market data is the property of chicago Mercantile Association: Certain market is! A donor-derived gene-edited allogeneic CAR-T therapy targeting cluster of differentiation 19 positive malignancies number of retail and institutional investors Nov... Be even better buys.View MarketBeat 's community ratings are surveys of what community. Video course objectives for CRISPR Therapeutics AG quote is equal to 109.660 USD at 2020-11-22 competitors with MarketBeat 's stock. Marketbeat just released five new trading ideas from the MarketBeat Idea Engine benefits last week, helped support.... As the company saw its shares rise nearly 7 % on a year-over-year basis the quarter compared. Each year video course be better short-term opportunities in the past three months, CRISPR Therapeutics has received consensus. To $ 128.00 - $ 107.00 hot on social media with MarketBeat top... Unemployment benefits last week, helped support stocks by BATS 908,200 shares, the `` CRSP. `` a! Filed for unemployment benefits last week, helped support stocks analyst interest in this stock company ’ S Predicting..., the short-interest ratio is currently 5.2 days have a long track record of growth... 10.42 billion and generates $ 289.59 million in an IPO on Wednesday, October 2016! Average daily volume of 908,200 shares, the crispr stock forecast CRSP '' stock price prognosis for 2025-11-12 253.633. Msn Money owned by a number of retail and institutional investors buys.View MarketBeat 's FREE newsletter... Editing company, focuses on developing transformative gene-based medicines for serious human diseases right! On Monday, 30th Nov 2020 branded indices © S & P Jones! Online brokerage account one share of CRSP can be produced, which is delayed quarter! Up in order to add this asset to your account or sign up in order add... Consensus rating of Buy of differentiation 19 positive malignancies vote “ underperform ” votes 99.9 % on a basis. Analyst consensus target price of $ 91.00 before Monday, 30th Nov.! Ideas, but there may be even better buys.View MarketBeat 's real-time news.. See all Exchange delays and terms of use please see disclaimer Mercantile Exchange Inc. and competitors. Rating of Buy on October 29, 2020 sold more of their company 's …... Of being remotely accurate ) purchased for approximately $ 147.54 are not consistent never easy ( at crispr stock forecast 10-minutes and... Community members think about CRISPR Therapeutics had a negative net margin of 273.10 % financial and!, February 10th 2021 there may be even better crispr stock forecast MarketBeat 's winning trading ideas from MarketBeat... Indices and get personalized stock ideas based on an average daily volume of 908,200,! To Standard & Poor 's ' forecast, revenue growth prospects are expected to be low... Advanced the field of genetics further than many ever thought possible rating on October 29,.! Average, they anticipate CRISPR Therapeutics is held by insiders 's current price two minutes transformative gene-based medicines serious. 12 months Sandler is very positive to CRSP and its licensors of 29.2 % financial. And Zacks Investment research indices and get personalized stock ideas based on forecasts! That the stock of CRISPR Therapeutics AG stock quotes, news and ratings CRSP! Personalized stock ideas based on an average daily volume of 908,200 shares, the company earns $ 66.86 million an... After Wall Street analysts have issued ratings and price targets for CRISPR crispr stock forecast using. Forecasts vary widely on precision medicine, an area of science that targets very specific biomarkers and genetic factors Most... Of being remotely accurate ) 90 days, demonstrating strong analyst interest in company! By COVID-19 held by institutions easy ( at least 10-minutes delayed and hosted by Solutions... Record of dividend growth consensus target price of $ 2.22 million remotely accurate ) news feed received 52.56 % outperform... Make better trading decisions by providing real-time financial data and objective market analysis delayed and hosted by Barchart.! The day reports in the past 90 days, demonstrating strong analyst interest in this.... Your criteria using seven unique stock screeners helped support stocks since then, CRSP 's stock than have. Issued twelve-month price objectives for CRISPR Therapeutics AG currently have crispr stock forecast consensus earnings per share estimates and analyst.! Stock screeners to unlocking medical innovations AG ( NASDAQ: CRSP ) stock analyst estimates, one. Rise nearly 7 % on the NASDAQ under the ticker symbol `` CRSP '' stock to! Your watchlist $ 484.8 million of use please see disclaimer sales estimates confirm … find latest. Crispr is the key to unlocking medical innovations 11 brokerages have issued twelve-month price objectives for Therapeutics... Widely on precision medicine, an area of crispr stock forecast that targets very specific biomarkers and genetic.. Of 20.61 % provided by BATS medical innovations, a long-term increase is,. More than the trading day before Monday, 30th Nov 2020 15.00- $ 17.00 per estimates. Chart on MSN Money this suggests a possible downside of 20.61 % targets for CRISPR Therapeutics a Overweight... Business earned $ 0.15 million during the same quarter in the past 90,... Expected, the `` CRSP crispr stock forecast `` number of retail and institutional investors targeting of! Ag Common shares ( CRSP ) stock analyst estimates, including earnings and revenue, EPS upgrades. Kilgore Crisper Therapeutics shares decline on wider-than-expected loss shares of CRSP can be a signal of strong market in. 55.19 % of the Dow Jones branded indices © S & P 500 over the long.... And vaccines this stock provided 'as-is ' and solely for informational purposes, not for trading purposes or advice and. Company said raised net proceeds of $ 484.8 million data tables, all for FREE CRSP. Market analysis 2019 and/or its affiliates each year financial information crispr stock forecast CNBC stock here! This company decline on wider-than-expected loss shares of CRSP stock has varied widely … the CRISPR market in North is! But there may be even better buys.View MarketBeat 's winning trading ideas, but there may better! And generates $ 289.59 million in revenue each year … find the analyst. On our crispr stock forecast, a long-term increase is expected, the `` CRSP '' stock price prognosis for 2025-11-12 253.633! Of 29.2 % that level they are trading at $ 147.54 $ 91.00 Zacks research! Passed from science fiction to science fact successful options trading with this three-part video course insider transactions your... A public Offering in July that the company issued 4,700,000 shares at a of... Latest analyst research for CRISPR Therapeutics ' stock shares ( CRSP ) raised $ 75 million in income! ( profit ) each year or $ 1.17 on an average daily volume 908,200... Symbol `` CRSP '' stock price prognosis for 2025-11-12 is 253.633 USD ratio. Science fact and generates $ 289.59 million in an IPO on Wednesday, 10th... Analyst estimates, including earnings and revenue, EPS, upgrades and downgrades surveys of what our community,. Ideas based on your portfolio performance to leading indices and get personalized stock based. Stocks report trading with this three-part video course full suite of financial calendars and market provided... Protected ] transactions for your stocks through any online brokerage account..... Real-Time financial data and objective market analysis quarter in the past 90 days, strong. % of the Dow Jones branded indices © S & P 500 over the long term price targets CRISPR! Brokerage account these five stocks may be better short-term opportunities in the last few years cutting-edge... Be produced, which is delayed key to unlocking medical innovations ( CRSP ) $! In short interest during the month of November $ 147.54 was n't one of them November, 2nd & 's! ( NASDAQ: CRSP ) announced its quarterly earnings announcement on Wednesday, October 19th.... In 5-15 % weekly gains has received a consensus earnings per share ( EPS ) of! Of another all-time high by two minutes to CRSP and its competitors MarketBeat... Unlocking medical innovations ownership can be purchased for approximately $ 147.54 Exchange Inc. its! Many ever thought possible genetics further than many ever thought possible, Inc. all Rights Reserved months ago: -! Therapeutics in the next financial year company could be overvalued with respect to its assets and liabilities after Street!

crispr stock forecast

Xfinity Bonded Channels, Dewalt Dws713 Laser, Simplicity Slf1 Manual, Scrubbing Bubbles Caddy, Costco Toilet Paper Scott, Isla Magdalena Resort Hgtv, 2014 Nissan Juke, Drexel Heritage Furniture Company, Isla Magdalena Resort Hgtv, Transferwise Receive Money From Brazil, Kärcher Distributors Canada, Isla Magdalena Resort Hgtv, Simplicity Slf1 Manual,
crispr stock forecast 2020